Form 4 Tracker
Viridian Therapeutics, Inc.\DE
VRDN

12 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 11, 2026May 13 8:31 PMFairmount Funds Management LLCDirector, 10% Owner
Purchase
1,176,470$17.00$20.0M5,090,928(I)

View →

Mar 4, 2026Mar 4 9:29 PMBeetham Thomas W.
Proposed Sale
3,048$30.19$92.0K

View →

Mar 4, 2026Mar 4 9:25 PMTousignant Jennifer
Proposed Sale
1,675$30.19$50.6K

View →

Mar 4, 2026Mar 4 9:20 PMHarmon Seth
Proposed Sale
2,031$30.19$61.3K

View →

Mar 4, 2026Mar 4 9:10 PMMahoney Stephen F.
Proposed Sale
7,408$30.19$223.6K

View →

Dec 31, 2025Dec 31 5:24 PMTousignant Jennifer
Proposed Sale
2,272$31.16$70.8K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 3, 2026Mar 5 12:17 AMJennifer TousignantChief Legal Officer
Option Exercise
5,16915,510(D)

View →

Mar 2, 2026Mar 5 12:17 AMJennifer TousignantChief Legal Officer
Grant/Award
143,150$30.2523,850(D)

View →

Mar 3, 2026Mar 5 12:15 AMSeth HarmonChief Financial Officer
Option Exercise
6,26718,801(D)

View →

Mar 2, 2026Mar 5 12:15 AMSeth HarmonChief Financial Officer
Grant/Award
123,400$30.2520,550(D)

View →

Mar 3, 2026Mar 4 11:58 PMThomas W. BeethamChief Operating Officer
Option Exercise
9,40928,227(D)

View →

Mar 2, 2026Mar 4 11:58 PMThomas W. BeethamChief Operating Officer
Grant/Award
211,850$30.2535,300(D)

View →

Mar 3, 2026Mar 4 11:56 PMStephen F. MahoneyPresident and CEO
Option Exercise
18,35755,071(D)

View →

Mar 2, 2026Mar 4 11:56 PMStephen F. MahoneyPresident and CEO
Grant/Award
671,500$30.25111,900(D)

View →

Mar 2, 2026Mar 4 11:51 PMRadhika TripuraneniChief Medical Officer
Grant/Award
114,950$30.2519,150(D)

View →